Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

Clinical trial NCT05067621 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05067621
Sponsor: Yale University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Impaired Glucose Tolerance Non-Alcoholic Fatty Liver Disease Obesity, Childhood

Start date: 2023-07-17
Primary completion: 2026-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.